Binder syndrome : a phenotype rather than a definitive diagnosis? by E. Mazzone et al.
Letters to the Editor 131
Binder syndrome: a phenotype rather than a
definitive diagnosis?
Binder syndrome is a congenital malformation charac-
terized by nasomaxillary hypoplasia. It can be isolated
or associated with multiple etiologies, such as maternal
intake of coumarin-based anticoagulants during preg-
nancy, systemic lupus erythematosus and some other
monogenic conditions, such as Keutel syndrome or chon-
drodysplasia punctata (CDP)1. We report the case of a
24-year-old primigravida referred to our fetal medicine
unit at 27 + 2 weeks’ gestation, following the finding of
significant fetal facial dysmorphism during a routine ultra-
sound examination at 23 weeks. Amniocentesis with a
traditional cell culture of the amniotic fluid followed by
array comparative genomic hybridization, 37 kb, revealed
a normal karyotype, 46XY. The woman’s medical history
was unremarkable.
Ultrasound examination and fetal magnetic resonance
imaging (MRI) performed in our center confirmed
facial malformation suggestive of Binder phenotype,
characterized by a flat nose and abnormal convexity
of the maxilla (Figure 1). Other findings included
abnormal epiphyseal ossification centers, short limbs and
brachytelephalangy. When Binder phenotype is diagnosed
prenatally, a thorough search for associated abnormalities
is mandatory in order to identify correctly the etiology, of
which one of the most important is CDP.
CDP is a heterogeneous group of congenital skele-
tal dysplasias. This condition may have a genetic cause
with several different inheritance patterns and, as in our
case, the clinical presentation of the X-linked recessive
type (CDPX1, brachytelephalangic type) includes Binder
phenotype, stippling calcifications and brachytelepha-
langy associated with hypoplastic nails2. CDPX1 is a
rare condition affecting only males, due to the X-linked
Figure 1 Facial profile of fetus with X-linked recessive chondrodysplasia punctata, as seen on two- (a) and three- (b) dimensional
ultrasound, magnetic resonance imaging (c) and postmortem examination (d), showing flat nasofrontal angle and verticalized nasal bones
typical of Binder phenotype. (e) Postmortem X-ray of same fetus, showing skeletal anomalies of chondrodysplasia punctata, including
hyperechoic focal calcifications (puncta) on femoral epiphyses (encircled area) and brachytelephalangy (hypoplasia of distal phalanges of
hands) (arrow). R, right.
recessive inheritance pattern. The condition is associated
with mutations either within the arylsulfatase E gene
(ARSE) or chromosomal deletions in the region of
the short arm of the X chromosome encompassing
ARSE3.
In the current case, the diagnosis of CDPX1 was
proposed following a multidisciplinary meeting between
perinatologists and geneticists. Given the variability of the
clinical manifestations and no clear genotype–phenotype
correlation, prenatal counseling was challenging. The
couple decided to terminate the pregnancy at 28 weeks’
gestation and the confirmed diagnosis of CDPX1 was
available only after completion of full postmortem
investigation.
Pathological examination confirmed Binder pheno-
type and brachytelephalangy. Multiple and abnormal
calcifications of the trachea and skeleton were also
found (Figure 1). Targeted genetic studies performed
on the amniotic fluid detected a hemizygous mutation
(c.1743G > A, p.Trp581) in ARSE, confirming the diag-
nosis of CDPX1 (Online Mendelian Inheritance in Man
(OMIM) number 302950).
To date, there are only two published reports
describing the prenatal diagnosis of CDPX1 based
on brachytelephalangy and stippling calcifications of
the femora and vertebrae4,5. In our case, Binder
phenotype, brachytelephalangy and abnormal epiphyseal
ossifications in a male fetus were identified prenatally
on ultrasound examination and confirmed on fetal
MRI.
In conclusion, tertiary-level conventional ultrasound
can be accurate for the prenatal diagnosis of CDP due
to the detection of Binder phenotype associated with
abnormal epiphyseal ossification centers and hypoplasia
of the distal phalanges of the hands. However, to identify
the specific type of CDP, targeted genetic analysis is
required.
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